Hassan, Mary Joy B.

HRN: 03-45-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/25/2023
02/01/2023
IV
300mg
Q6h
Fracture
Waiting Final Action 
01/25/2023
CEFTRIAXONE 1G (VIAL)
01/25/2023
02/01/2023
IV
1g
Q12
Fracture
Waiting Final Action 
01/30/2023
CLINDAMYCIN 300MG (CAP)
01/30/2023
02/06/2023
PO
300mg
Q8hrs
Fx On Femur
Waiting Final Action 
01/30/2023
CO-AMOXICLAV 625MG (TAB)
01/30/2023
02/06/2023
PO
625mg
Q8hrs
Fx Femur Left
Waiting Final Action 
05/16/2023
CEFUROXIME 1.5GM (VIAL)
05/16/2023
05/23/2023
IV
1.5 G
Q8h
Closed Fx; Implant Failure
Waiting Final Action 
05/23/2023
CEFUROXIME 500MG (TAB)
05/23/2023
05/30/2023
ORAL
500 Mg
BID
S/P Appendectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: